XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Jul. 01, 2023
Jul. 02, 2022
OPERATING ACTIVITIES    
Net income (loss) $ 88.3 $ (217.5)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Impairment, restructuring and other 50.0 641.8
Deferred taxes (5.9) (162.7)
Share-based compensation expense 52.7 28.6
Depreciation 49.6 50.3
Amortization 20.8 28.5
Equity in income of unconsolidated affiliates (3.5) (1.3)
Other, net 0.4 0.5
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable (775.9) (467.7)
Inventories 448.6 (256.6)
Prepaid and other current assets (0.7) (36.1)
Accounts payable (35.7) (288.3)
Other current liabilities 112.5 (16.4)
Other non-current items (8.1) 20.6
Other, net 2.6 (3.3)
Net cash used in operating activities (4.3) (679.6)
INVESTING ACTIVITIES    
Proceeds from sale of long-lived assets 1.9 9.4
Investments in property, plant and equipment (73.8) (99.0)
Proceeds from loans receivable 37.0 0.0
Payment for acquisitions, net of cash acquired 0.0 (237.3)
Purchase of convertible debt investments 0.0 (25.0)
Other investing, net (9.7) 17.4
Net cash used in investing activities (44.6) (334.5)
FINANCING ACTIVITIES    
Borrowings under revolving and bank lines of credit and term loans 1,296.4 3,440.0
Repayments under revolving and bank lines of credit and term loans (1,183.8) (2,253.3)
Financing and issuance fees 0.0 (9.7)
Dividends paid (112.0) (129.6)
Purchase of Common Shares (9.3) (257.7)
Cash received from exercise of stock options 1.7 2.6
Other financing, net (4.0) 5.6
Net cash (used in) provided by financing activities (11.0) 797.9
Effect of exchange rate changes on cash 0.5 (0.1)
Net decrease in cash and cash equivalents (59.4) (216.3)
Cash and cash equivalents at beginning of period 86.8 244.1
Cash and cash equivalents at end of period $ 27.4 $ 27.8